Recombinant Mouse SPG21 Protein (Baculovirus)，His

SPG21, also known as Spastic Paraplegia 21, is a gene associated with hereditary spastic paraplegia (HSP), a group of neurodegenerative disorders characterized by progressive weakness and stiffness of the lower limbs. The SPG21 gene encodes a protein called spatacsin, which is believed to play a crucial role in maintaining neuronal function and membrane integrity. Mutations in the SPG21 gene lead to the accumulation of damaged organelles and impaired autophagy, ultimately resulting in neurodegeneration and clinical symptoms of HSP. Research into the structure and function of SPG21 recombinant protein is essential for understanding the underlying mechanisms of the disease and developing potential therapeutic strategies. Scientists have been focusing on producing and characterizing SPG21 recombinant protein to investigate its interactions with other cellular components and its role in cellular processes. By utilizing advanced techniques such as X-ray crystallography and cryo-electron microscopy, researchers aim to elucidate the protein's three-dimensional structure and gain insights into how specific mutations affect its functionality. Understanding these molecular details is crucial for uncovering the pathophysiology of HSP caused by SPG21 mutations and may pave the way for targeted treatments, such as gene therapy or small molecules that can modulate the cellular pathways affected by spatacsin dysfunction. Therefore, the study of SPG21 recombinant protein not only enhances our comprehension of hereditary spastic paraplegia but also represents a promising avenue for future research and therapeutic intervention in this debilitating condition.